CT Triphasic with Contrast at Lahore PCR Lab

CT Triphasic with Contrast at Lahore PCR Lab

A CT Triphasic with Contrast at Lahore PCR Lab is a highly specialized, non-invasive diagnostic imaging procedure designed to evaluate abdominal organs, with a primary focus on the liver, pancreas, kidneys, and associated vascular structures. Unlike a standard single-phase computed tomography scan, a triphasic CT scan captures multiple sets of images at highly precise intervals following the intravenous administration of an iodinated contrast agent. This advanced imaging protocol allows consultant radiologists to observe how contrast media flows through the arterial, portal venous, and delayed phases of tissue perfusion. By analyzing these distinct phases, medical specialists can differentiate between benign and malignant lesions, map complex vascular anatomy, and diagnose hepatobiliary disorders with exceptional clinical accuracy.

The technology utilized at Lahore PCR Lab involves multi-detector computed tomography (MDCT) scanners. These modern scanners emit narrow beams of X-rays that rotate rapidly around the patient, generating cross-sectional slices of the abdominal cavity. The integration of high-speed detectors and advanced reconstruction software ensures that images are acquired rapidly, minimizing motion artifacts caused by respiration or bowel peristalsis. The clinical importance of a triphasic scan lies in its ability to exploit the unique dual blood supply of the liver. While normal liver tissue receives approximately 75% of its blood from the portal vein and 25% from the hepatic artery, primary hepatic tumors such as hepatocellular carcinoma (HCC) derive nearly 100% of their blood supply from the hepatic artery. Capturing the arterial phase is therefore critical for detecting hypervascular lesions that would otherwise remain invisible on routine scans.

The primary anatomy evaluated during a CT Triphasic with Contrast includes the hepatic parenchyma, hepatic arteries, portal venous system, hepatic veins, gallbladder, biliary tree, pancreas, spleen, adrenal glands, kidneys, and retroperitoneal vasculature. This comprehensive evaluation provides immense diagnostic value, particularly for patients presenting with suspected liver tumors, pancreatic masses, or complex vascular anomalies. The benefits of undergoing this scan at Lahore PCR Lab include highly detailed anatomical visualization, rapid acquisition times, and precise characterization of indeterminate lesions. Common clinical indications for this procedure include the evaluation of chronic liver disease, staging of known abdominal malignancies, pre-operative planning for liver resection or transplantation, and the investigation of abnormal liver function tests or elevated tumor markers such as alpha-fetoprotein (AFP).

Clinical Procedure: What to Expect

Patient Preparation

Proper patient preparation is essential to ensure image quality, patient safety, and diagnostic accuracy during a CT Triphasic with Contrast at Lahore PCR Lab. Patients are advised to follow these guidelines closely:

• Fasting Requirements: Patients must fast (NPO) for at least 4 to 6 hours prior to the scheduled scan. This helps reduce bowel activity and ensures optimal visualization of the gallbladder and surrounding abdominal structures. Clear liquids, such as water, are generally permitted up to two hours before the procedure.
• Kidney Function Assessment: Because the procedure requires the injection of an intravenous iodinated contrast agent, patients must provide a recent Serum Creatinine and estimated Glomerular Filtration Rate (eGFR) report. This is crucial to ensure that the kidneys can safely filter and excrete the contrast medium.
• Allergy Screening: Patients must inform the clinical staff of any history of allergies, particularly previous adverse reactions to contrast media, iodine, or shellfish. If a moderate-to-severe allergy is documented, a pre-medication protocol involving corticosteroids and antihistamines may be prescribed by the referring physician.
• Medication Management: Patients taking metformin for diabetes must discuss this with their physician. Metformin may need to be temporarily discontinued on the day of the scan and withheld for 48 hours post-procedure, pending confirmation of normal renal function. Other routine medications can typically be taken with a small sip of water.
• Comfortable Attire: It is recommended to wear loose, comfortable clothing. Patients will be asked to change into a hospital gown and remove all metallic objects, including jewelry, belts, zippers, and piercings, as metal can cause severe streak artifacts on the CT images.
• Pregnancy Screening: Female patients of childbearing age must inform the technologist if there is any possibility of pregnancy. Due to the use of ionizing radiation, alternative imaging modalities such as ultrasound or magnetic resonance imaging (MRI) may be considered unless the clinical benefit of the CT scan outweighs the potential risks.

During the Procedure

Upon arriving at the imaging department of Lahore PCR Lab, the patient’s medical history, laboratory reports, and consent forms will be verified by the clinical team. A qualified nurse or radiographer will insert an intravenous (IV) cannula, typically into a large vein in the antecubital fossa of the arm. This cannula is connected to an automated dual-head power injector, which precisely controls the rate and volume of the contrast medium delivery.

The patient is positioned supine (lying on their back) on the motorized CT scanner table. To ensure stability and minimize movement, comfortable straps or cushions may be utilized. The table then glides smoothly into the circular opening of the CT gantry. The technologist operates the scanner from an adjacent control room, maintaining continuous visual and auditory communication with the patient through an intercom system. The patient will be instructed to hold their breath for brief intervals (usually 10 to 15 seconds) during image acquisition to eliminate respiratory motion.

The triphasic scanning sequence begins with a preliminary unenhanced (plain) scan of the abdomen. This serves as a baseline to evaluate calcifications, fat content, or pre-existing hemorrhage. Next, the automated injector administers the iodinated contrast agent at a rapid rate (typically 3 to 5 mL per second). The scanner then performs three successive passes at highly specific time points:

• Late Arterial Phase (25 to 35 seconds post-injection): This phase captures the contrast as it fills the hepatic arteries and hypervascular lesions, such as hepatocellular carcinoma or hepatic adenomas, which show intense early enhancement.
• Portal Venous Phase (60 to 70 seconds post-injection): During this phase, the contrast circulates through the portal vein, maximally enhancing the normal liver parenchyma. This phase is optimal for identifying hypovascular metastases, portal vein thrombosis, and general abdominal anatomy.
• Delayed / Equilibrium Phase (3 to 5 minutes post-injection): This final phase evaluates the washout of contrast from lesions and is highly useful for characterizing specific tumor types, such as cholangiocarcinoma or hemangiomas, which exhibit progressive contrast retention or peripheral nodular filling.

During the contrast injection, patients commonly experience a transient warm sensation spreading throughout the body, a metallic taste in the mouth, or the brief sensation of needing to urinate. These are normal physiological responses and resolve rapidly. The entire imaging process takes approximately 15 to 20 minutes, after which the IV cannula is removed, and the patient is monitored briefly before discharge.

When is a CT Triphasic with Contrast Performed?

Evaluation of Focal Liver Lesions

Physicians frequently request a triphasic CT scan when an indeterminate liver mass is detected on a routine abdominal ultrasound or standard CT scan. Symptoms such as persistent right upper quadrant pain, unexplained weight loss, or palpable hepatomegaly warrant this investigation. The triphasic protocol is the gold standard for characterizing focal liver lesions, allowing radiologists to differentiate benign lesions like hemangiomas, focal nodular hyperplasia (FNH), and hepatic adenomas from malignant tumors like hepatocellular carcinoma (HCC) or intrahepatic cholangiocarcinoma based on their distinct vascular enhancement patterns.

Staging and Monitoring of Hepatic Metastases

For patients diagnosed with primary extrahepatic malignancies, such as colorectal, pancreatic, gastric, breast, or lung cancer, the liver is a common site for metastatic spread. Oncologists utilize the CT Triphasic with Contrast to detect, stage, and monitor liver metastases. While some metastases are hypervascular, many are hypovascular and appear most prominent during the portal venous phase as dark, hypoattenuating lesions against the brightly enhancing normal liver tissue. Accurate detection of these lesions is vital for determining the patient’s cancer stage and evaluating response to chemotherapy or targeted therapies.

Assessment of Pancreatic Masses and Neuroendocrine Tumors

The pancreas is a highly vascular organ, and tumors arising within it require precise multiphase evaluation. Patients presenting with painless jaundice, significant weight loss, or new-onset diabetes may be suspected of having pancreatic adenocarcinoma or pancreatic neuroendocrine tumors (pNETs). A triphasic scan helps delineate the relationship of a pancreatic mass to major surrounding blood vessels, such as the celiac trunk, superior mesenteric artery, and portal vein. This vascular mapping is critical for determining tumor resectability and planning surgical interventions.

Pre-Operative Planning for Liver Resection or Transplantation

In patients scheduled for major hepatobiliary surgery, such as partial hepatectomy or living donor liver transplantation, a detailed understanding of the vascular anatomy is paramount. Surgeons require precise maps of the hepatic arterial branches, portal vein anatomy, and hepatic venous drainage to avoid catastrophic intraoperative complications. The high-resolution arterial and venous phase images obtained during a triphasic CT scan provide three-dimensional vascular reconstructions that guide surgical planning and ensure patient safety.

Investigation of Portal Hypertension and Cirrhosis

Chronic liver diseases, including hepatitis B, hepatitis C, and non-alcoholic steatohepatitis (NASH), can progress to liver cirrhosis. Patients with cirrhosis are at high risk for developing portal hypertension and hepatocellular carcinoma. Gastroenterologists and hepatologists utilize the triphasic CT scan to monitor cirrhotic patients for early-stage HCC, assess the patency of the portal and hepatic veins, and detect signs of portal hypertension such as splenomegaly, ascites, and extensive portosystemic collateral pathways (varices).

What Does a CT Triphasic with Contrast Detect?

A CT Triphasic with Contrast is an exceptionally sensitive diagnostic tool capable of identifying a wide spectrum of hepatobiliary, pancreatic, and systemic pathologies. The primary findings detected by this scan include:

• Hepatocellular Carcinoma (HCC): Characterized by intense, heterogeneous enhancement during the arterial phase followed by rapid contrast washout in the portal venous and delayed phases.
• Hepatic Hemangioma: Shows classic peripheral, globular, discontinuous enhancement during the arterial phase with progressive centripetal fill-in on delayed images.
• Focal Nodular Hyperplasia (FNH): Displays rapid, uniform arterial enhancement with a non-enhancing central stellate scar that may show delayed enhancement.
• Hepatic Adenoma: Demonstrates early arterial enhancement with variable washout, often containing areas of fat or hemorrhage.
• Hypervascular Metastases: Rapidly enhancing lesions during the arterial phase, commonly originating from neuroendocrine tumors, renal cell carcinoma, or thyroid cancer.
• Hypovascular Metastases: Lesions that appear hypoattenuating relative to the liver parenchyma during the portal venous phase, typical of colorectal or gastric primaries.
• Cholangiocarcinoma: Shows delayed, progressive enhancement due to its fibrous stroma, often associated with localized bile duct dilatation.
• Portal Vein Thrombosis: Identified as a filling defect within the portal vein, which can be bland (clot) or tumor-related (neoplastic invasion).
• Budd-Chiari Syndrome: Characterized by hepatic vein occlusion, hepatomegaly, caudate lobe hypertrophy, and patchy, mottled liver enhancement.
• Liver Cirrhosis: Evidenced by a nodular liver contour, atrophy of the right lobe, hypertrophy of the caudate and left lobes, and widening of the fissures.
• Portal Hypertension: Indicated by the presence of splenomegaly, ascites, and collateral vessels such as esophageal, gastric, or recanalized umbilical varices.
• Hepatic Steatosis (Fatty Liver): Diagnosed by a diffuse decrease in hepatic attenuation on the unenhanced scan, making the liver appear darker than the spleen.
• Hepatic Abscess: Appears as a fluid-filled cavity with a well-defined, thick, enhancing wall, often showing a “cluster sign” of multiple small confluent cavities.
• Pancreatic Adenocarcinoma: Typically presents as an ill-defined, hypoenhancing mass during the late arterial/pancreatic phase, often causing dilatation of the pancreatic and common bile ducts (double duct sign).
• Pancreatic Neuroendocrine Tumors: Highly vascular lesions that demonstrate robust, uniform enhancement during the arterial phase.
• Splenomegaly: Pathological enlargement of the spleen, often secondary to portal hypertension, hematologic malignancies, or infectious processes.
• Renal Cell Carcinoma (RCC): Hypervascular renal masses that show prominent enhancement in the corticomedullary phase of the scan.
• Abdominal Aortic Aneurysm (AAA): Focal dilatation of the abdominal aorta, with the contrast helping to delineate the true and false lumens, thrombus presence, and branch involvement.
• Biliary Duct Dilatation: Dilatation of the intrahepatic or extrahepatic bile ducts, secondary to choledocholithiasis, strictures, or periampullary tumors.
• Lymphadenopathy: Enlargement of retroperitoneal, mesenteric, or porta hepatis lymph nodes, indicating metastatic spread, lymphoma, or chronic inflammation.

Turnaround Time and Report Access at Lahore PCR Lab

At Lahore PCR Lab, we understand that timely diagnostic results are crucial for effective clinical decision-making and patient peace of mind. Following the completion of your CT Triphasic with Contrast scan, the extensive dataset containing hundreds of high-resolution cross-sectional images is transferred to our advanced picture archiving and communication system (PACS). A highly qualified consultant radiologist specializing in abdominal imaging meticulously reviews the unenhanced, arterial, portal venous, and delayed phase scans, comparing them with any available prior imaging studies.

The comprehensive diagnostic report, detailing anatomical findings, vascular patency, and lesion characteristics, is typically finalized within 24 to 48 hours. Patients and referring physicians can access these reports and the associated digital imaging DICOM files securely through the Lahore PCR Lab online patient portal. Physical copies of the report and high-quality printed films or digital media (CD/USB) can also be collected directly from our diagnostic center. Our administrative staff is dedicated to ensuring a seamless, professional reporting process to facilitate prompt medical consultation and treatment planning.

CT Triphasic with Contrast Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Hepatic Parenchyma	Homogeneous attenuation on unenhanced scan; uniform enhancement in portal venous phase.	Hepatocellular carcinoma (arterial wash-in, delayed wash-out); hemangiomas; metastases; abscesses.
Hepatic Arteries	Normal caliber, patency, and anatomical branching without stenosis or aneurysmal dilatation.	Aneurysms, stenosis, anatomical variants (e.g., replaced right hepatic artery), or tumor encasement.
Portal Venous System	Complete patency of the main portal vein, splenic vein, and superior mesenteric vein; normal hepatopetal flow.	Portal vein thrombosis (bland or tumor thrombus), cavernous transformation, or variceal collaterals.
Pancreatic Parenchyma	Normal size, lobulated architecture, and uniform enhancement; clear surrounding fat planes.	Hypoenhancing pancreatic adenocarcinoma, hyperenhancing neuroendocrine tumors, or acute/chronic pancreatitis.
Spleen	Homogeneous enhancement (often mottled in early arterial phase); normal size (craniocaudal length < 12 cm).	Splenomegaly, splenic infarcts, lacerations, or hypervascular lesions.
Biliary Tree	No intrahepatic or extrahepatic biliary ductal dilatation; gallbladder thin-walled and stone-free.	Choledocholithiasis, biliary strictures, cholangiocarcinoma, or acute cholecystitis with wall thickening.
Abdominal Lymph Nodes	No pathologically enlarged retroperitoneal, mesenteric, or pelvic lymph nodes (short-axis diameter < 10 mm).	Lymphadenopathy secondary to metastatic malignancy, lymphoma, tuberculosis, or sarcoidosis.
Peritoneal Cavity	No free fluid (ascites), abnormal soft tissue masses, or peritoneal thickening/enhancement.	Ascites, peritoneal carcinomatosis (omental caking), or loculated fluid collections/abscesses.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Lahore PCR Lab for CT Triphasic with Contrast?

• Experienced Healthcare Professionals: Our diagnostic team comprises highly trained consultant radiologists and technologists specializing in advanced multi-phase computed tomography.
• Patient-Focused Care: We prioritize patient comfort, safety, and clear communication throughout the entire preparation and scanning process.
• Quality Diagnostic Services: Lahore PCR Lab is committed to delivering high-resolution diagnostic imaging that meets international quality standards.
• Professional Reporting: Our detailed, structured imaging reports provide clear, actionable diagnostic insights to assist your referring physician.
• Modern Diagnostic Approach: We utilize advanced multi-slice CT technology and automated contrast injectors to ensure precise scan timing and optimal image quality.
• Comfortable Environment: Our diagnostic center in Lahore is designed to provide a clean, welcoming, and stress-free environment for all patients.
• Convenient Location: Located centrally in Lahore, Pakistan, our facility is easily accessible for patients seeking reliable diagnostic services.
• Commitment to Accurate Diagnosis: We implement rigorous quality control protocols to ensure the highest level of diagnostic accuracy in every scan we perform.